Economic impact of cardiovascular co-morbidity in patients with type-2 diabetes

被引：0
|
作者：
Mody, R
Kalsekar, I
Kavookjian, J
Iyer, S
Rajagopalan, R
Pawar, V
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Butler Univ, Indianapolis, IN 46208 USA
[3] Takeda Pharmaceut N Amer Inc, Lincolnshire, IL USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62957-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [31] Co-morbidity burden and incident hypoglycaemia in patients with type 2 diabetes and heart failure: insight from DiaRegis
    Tschoepe, D.
    Binz, C.
    Bramlage, P.
    Krekler, M.
    Plate, T.
    Deeg, E.
    Gitt, A. K.
    [J]. DIABETOLOGIA, 2011, 54 : S500 - S500
  • [32] Diabetes and psychological co-morbidity in children with a family history of early-onset type 2 diabetes
    Irving, Rachael R.
    Mills, James L.
    Choo-Kang, Eric G.
    Mclaughlin, Wayne
    Wright-Pascoe, Rosemarie
    Morrison, Errol Y.
    Brown, Paul
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2008, 43 (06) : 937 - 942
  • [33] Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry
    Jürgen Wasem
    Peter Bramlage
    Anselm K Gitt
    Christiane Binz
    Michael Krekler
    Evelin Deeg
    Diethelm Tschöpe
    [J]. Cardiovascular Diabetology, 12
  • [34] Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy - an analysis of the DiaRegis registry
    Wasem, Juergen
    Bramlage, Peter
    Gitt, Anselm K.
    Binz, Christiane
    Krekler, Michael
    Deeg, Evelin
    Tschoepe, Diethelm
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [35] CO-MORBIDITY BETWEEN DEPRESSION AND CARDIOVASCULAR DISEASE
    Halaris, A.
    [J]. PSYCHIATRY AND THE NEUROSCIENCES: INTERNATIONAL PERSPECTIVES, 2011, : 163 - 169
  • [36] Predictor for cardiovascular risk in patients with type-2 diabetes mellitus
    Azharuddin, Md
    Kapur, Prem
    Mishra, Ritu
    Saleem, Shakir
    Gupta, Ashok Kumar
    Adil, Mohammad
    Sharma, Manju
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [37] CARDIOVASCULAR CO-MORBIDITY AMONG PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Dunn, Terence Sean
    Lenneman, Carrie
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1785 - 1785
  • [38] Co-morbidity impact on survival in irradiated prostate cancer patients
    Ferre, F.
    Gomez, D.
    Foro, P.
    Auhon, C.
    Vinals, R.
    Lacruz, M.
    Reig, A.
    Rodriguez, N.
    Sanz, X.
    Algara, M.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 237 - 237
  • [39] THE IMPACT OF CO-MORBIDITY ON HRQOL IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS
    Geryk, Lorie L.
    Carpenter, Delesha M.
    Blalock, Susan J.
    Devellis, Robert F.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2015, 49 : S235 - S235
  • [40] LITERATURE REVIEW OF THE IMPACT OF OBESITY ON CARDIOVASCULAR OUTCOMES IN THE GENERAL POPULATION AND IN PATIENTS WITH TYPE-2 DIABETES
    Smith-Palmer, J.
    Kalsekar, A.
    Boye, K. S.
    Goodall, G.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A96 - A97
12345